Restek Appoints New CEO
Bill Arrowsmith takes over for Bryan Wolcott, who retired from the position at the end of last year.
Restek Corporation, a provider of chromatography consumables, has announced the retirement of Bryan Wolcott, president and CEO, on December 31, 2023. With over 26 years of dedicated service, Wolcott served as Restek’s chief executive starting back in 2010, according to a press release from the company. He will remain a member of Restek’s Board of Directors.
Bill Arrowsmith will take over as the company’s CEO. Arrowsmith joined Restek back in 2017, when he served as the company’s chief financial officer before taking on the role of general manager in January 2023. As chief executive, Arrowsmith will be tasked with driving Restek's growth and development.
Prior to joining Restek, Arrowsmith held various finance and general management positions with companies such as Ernst & Young, AMETEK, and PwC. He holds a BS degree in accounting and international business from Pennsylvania State University and an MBA from Cornell University.
Restek is headquartered in Bellefonte, Pennsylvania. Founded in 1985, it has established officers in Japan, Germany, China, France, Italy, and United Kingdom. Restek is a provider of manufacturing and distributing high-quality instrument consumables, chromatography columns, sample preparation materials, scientific supplies, and reference standards.
This article was written with the help of artificial intelligence and has been edited to ensure accuracy and clarity. You can read more about our policy for using AI here.
Simultaneous Screening of Pesticide Residues in Date Fruits with UHPLC–MS/MS and GC–MS/MS
March 7th 2025Comprehensive information was derived through the utilization of a QuEChERS-UHPLC–MS/MS and GC–MS/MS method for the detection of 211 volatile and stable pesticide residues in 90 date fruit samples.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Pick Your Poison. Isolation of Paclitaxel (Mar 2025)
March 7th 2025The diterpenoid, paclitaxel, which was identified as a potent chemotherapy agent for breast and ovarian cancer originates from the Pacific Yew tree. The isolation of paclitaxel from its major impurities is shown with the use of Hamilton’s PRP-1 (5 µm) HPLC column.
